Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Phase I Clinical Trial to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers

NCT03908957 is registered in ClinicalTrials.gov with National Atomic Research Institute, Taiwan as lead sponsor.

NCT NCT03908957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03908957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Phase I Clinical Trial to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers
Lead sponsor
National Atomic Research Institute, Taiwan
Phase
Phase 1
Overall status
Completed
Start date
February 12, 2019
Completion date
August 9, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues